Replies to post #26226 on Biotech Values

[spartex]

Nicole Provost's presentation and panel questions start on page 135 in the link below.


http://www.fda.gov/ohrms/dockets/ac/06/transcripts/2006-4205T1.pdf

[io_io]

Spartex re: DNDN

Thnkx for posting this; a month old but I had missed it. Reinforcing for Provenge in HRPC, and optimism too in HDPC.

If you're long, suggest stick it out, we may be only 12 -18 months from approval. I am very optimistic.

[DewDiligence]

>[DNDN] You can see why if a group from CBER gets to be on Provenge’s advisory panel, Provenge’s chances for approval greatly increase. These people seem to recognize a good thing when they see it.<

Silly, silly, silly! DNDN longs must be nervous Nellies to resort to talking about the composition of the advisory panel.